Effects of the Mechanical Peripheral Stimulation for Parkinson's Disease Rehabilitation

January 11, 2017 updated by: Aline de Souza Pagnussat, Federal University of Health Science of Porto Alegre

Effects of the Mechanical Peripheral Stimulation for Parkinson's Disease Rehabilitation - A Randomized Clinical Trial

The purpose of this study is to evaluate safety and effectiveness of the peripheral mechanical stimulation of the feet on gait variables, clinical status, risk of falls, BDNF levels, immunological profile and brain functional connectivity changes in patients with Parkinson's disease.

Study Overview

Status

Completed

Conditions

Detailed Description

Patients will be submitted to 8 sessions of peripheral mechanical stimulation of the feet or sham stimulation along 4 weeks.

Evaluations will be performed before and after the first session, after the forth and the eighth session.

Study Type

Interventional

Enrollment (Actual)

28

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Rio Grande do Sul
      • Porto Alegre, Rio Grande do Sul, Brazil, 90050-170
        • Universidade Federal de Ciências da Saúde de Porto Alegre

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

50 years to 85 years (ADULT, OLDER_ADULT)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Diagnosis of idiopathic Parkinson's disease based on clinical criteria, dopamine transporter (DaT) scans and/or magnetic resonance imaging;
  • Able to walk 25 feet unassisted or with minimal assistance;
  • Presenting freezing of gait;
  • Aged between 50-85 years;
  • Minimum score of 20 in the Mini Mental State Examination (MMSE);

Exclusion Criteria:

  • Secondary musculoskeletal disorder involving the lower limb, as chondral injuries, ligament and ankle sprains which may impede the realization of the gait by pain or motion disability;
  • Peripheral neuropathy;
  • Not attending all the treatment;
  • Absolute contraindications for fMRI (just for fMRI examination);
  • Presence of deep brain stimulation;

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: TREATMENT
  • Allocation: RANDOMIZED
  • Interventional Model: PARALLEL
  • Masking: QUADRUPLE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Feet Mechanical Stimulation
The feet mechanical stimulation will be given to all participants using GONDOLA equipment (Ecker Technologies Sagl, Switzerland). Intervention: Device: Foot Mechanical Stimulation (GONDOLA)
Other Names:
  • GONDOLA equipment (Ecker Technologies Sagl, Switzerland)
Sham Comparator: Sham Feet Mechanical Stimulation
The sham stimulation will be given to all participants using GONDOLA equipment (Ecker Technologies Sagl, Switzerland). Intervention: Device: Foot Mechanical Stimulation (GONDOLA)
Other Names:
  • GONDOLA equipment (Ecker Technologies Sagl, Switzerland)

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Kinetic and kinematic gait analysis
Time Frame: 4 weeks of treatment
Evaluated by means of the 3-D motion analysis system (BTS SMART DX 400).
4 weeks of treatment

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Risk of falls
Time Frame: 4 weeks of treatment
Evaluated by means of the Timed Up & Go Test (TUG).
4 weeks of treatment
Motor impairment
Time Frame: 4 weeks of treatment
Evaluated by means of the Unified Parkinson Disease Rating Scale (UPDRS III).
4 weeks of treatment
Level of depression
Time Frame: 4 weeks of treatment
Evaluated by means of the Beck Depression Inventory (BDI).
4 weeks of treatment
Symptoms of Parkinson's disease progress
Time Frame: 4 weeks of treatment
Evaluated by means of the Hoehn and Yahr scale.
4 weeks of treatment
Serum levels of BDNF
Time Frame: 4 weeks of treatment
Analyzed in blood sampling.
4 weeks of treatment
Sensorio-motor connectivity
Time Frame: 4 weeks of treatment
Functional magnetic resonance imaging.
4 weeks of treatment
Lymphocyte Proliferation Assessment
Time Frame: 4 weeks of treatment
Analyzed in blood sampling.
4 weeks of treatment
Cytokine and Cortisol Assessment
Time Frame: 4 weeks of treatment
Analyzed in blood sampling.
4 weeks of treatment

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

December 1, 2015

Primary Completion (Actual)

September 1, 2016

Study Completion (Actual)

September 1, 2016

Study Registration Dates

First Submitted

October 30, 2015

First Submitted That Met QC Criteria

October 30, 2015

First Posted (Estimate)

November 3, 2015

Study Record Updates

Last Update Posted (Estimate)

January 12, 2017

Last Update Submitted That Met QC Criteria

January 11, 2017

Last Verified

January 1, 2017

More Information

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Parkinson's Disease

Clinical Trials on Mechanical Peripheral Stimulation (GONDOLA)

3
Subscribe